Bank of New York Mellon
KRRO icon

Bank of New York Mellon’s Korro Bio KRRO Stock Holding History

Bank of New York Mellon’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Buy
31,730
+10,000
+46% +$124K ﹤0.01% 3836
2026
Q1 		$246K Buy
21,730
+2,875
+15% +$31.7K ﹤0.01% 3926
2025
Q4 		$151K Sell
18,855
-458
-2% -$10.7K ﹤0.01% 4070
2025
Q3 		$925K Buy
19,313
+2,791
+17% +$61.9K ﹤0.01% 3252
2025
Q2 		$206K Buy
16,522
+409
+3% +$5.89K ﹤0.01% 3971
2025
Q1 		$281K Buy
16,113
+1,325
+9% +$39.3K ﹤0.01% 3731
2024
Q4 		$563K Buy
14,788
+435
+3% +$22.4K ﹤0.01% 3458
2024
Q3 		$480K Sell
14,353
-4,795
-25% -$202K ﹤0.01% 3540
2024
Q2 		$649K Buy
+19,148
New +$1.06M ﹤0.01% 3432
2023
Q4 		– Sell
-319
Closed -$5.89K – 4349
2023
Q3 		$5.89K Hold
319
– – ﹤0.01% 4324
2023
Q2 		$5.51K Hold
319
– – ﹤0.01% 4366
2023
Q1 		$8.01K Hold
319
– – ﹤0.01% 4366
2022
Q4 		$61.3K Hold
319
– – ﹤0.01% 4207
2022
Q3 		$29K Hold
319
– – ﹤0.01% 4402
2022
Q2 		$24K Sell
319
-1,993
-86% -$135K ﹤0.01% 4478
2022
Q1 		$246K Sell
2,312
-27
-1% -$5.16K ﹤0.01% 4129
2021
Q4 		$600K Sell
2,339
-18
-0.8% -$5.47K ﹤0.01% 3682
2021
Q3 		$832K Buy
2,357
+168
+8% +$66.1K ﹤0.01% 3503
2021
Q2 		$1.09M Buy
2,189
+171
+8% +$83.5K ﹤0.01% 3357
2021
Q1 		$958K Sell
2,018
-57
-3% -$111K ﹤0.01% 3353
2020
Q4 		$3.66M Buy
2,075
+374
+22% +$494K ﹤0.01% 2510
2020
Q3 		$1.63M Buy
1,701
+39
+2% +$41.9K ﹤0.01% 2785
2020
Q2 		$1.93M Buy
1,662
+1,224
+279% +$1.11M ﹤0.01% 2709
2020
Q1 		$391K Buy
438
+224
+105% +$242K ﹤0.01% 3488
2019
Q4 		$187K Buy
+214
New +$166K ﹤0.01% 3931

Other funds holding KRRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

Bank of New York Mellon's KRRO Position: Q2 2026 in Review

Bank of New York Mellon increased its Korro Bio (KRRO) stake by 46% in Q2 2026, buying an estimated $124K and bringing the position to 31,730 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #3836.

Bank of New York Mellon first reported a position in KRRO in Q4 2019 and has held it in 25 quarters since. The position peaked at $3.66M in Q4 2020. 39 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Bank of New York Mellon held 31,730 shares of Korro Bio worth $418K as of Q2 2026.
  • Bank of New York Mellon bought 10,000 Korro Bio shares in Q2 2026, an estimated $124K.
  • Korro Bio made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3836 holding.
  • Bank of New York Mellon first reported a position in Korro Bio in Q4 2019 and has held it in 25 quarters since.
  • Bank of New York Mellon's Korro Bio position peaked at $3.66M in Q4 2020.
  • 39 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.